Woman walking in a park with trees in the background. Outlines of medical professionals are super imposed with the text "ECG, Defibrillation, Heart Rate Reports, and Activity Trends" Woman walking in a park with trees in the background. Outlines of medical professionals are super imposed with the text "ECG, Defibrillation, Heart Rate Reports, and Activity Trends"

Consistent Performance

LifeVest® is proven safe and effective in extensive peer-reviewed clinical research and robust patient experience.

Trusted to protect 1M+ patients over 20 years
Demonstrated survival benefit in a study of 2,000 U.S. patients. 96% one-year survival across all patients (citation 1). 90% one-year survival in patients who experienced VT/VF (citation 1)

View LifeVest Results
Clinical research across 20,000+ patients of multiple etiologies.

Better Outcomes

LifeVest, when worn, provides patients with better outcomes.2 As seen in the 2020 VEST per-protocol analysis, patients that wore LifeVest realized significant mortality reductions in the first 90 days after a cardiac event.

Dive deeper into the VEST Trial
See full results from the intent-to-treat and per-protocol analyses.

ZOLL LifeVest: Data Insight

LifeVest combines SCD protection with better insight2,3 to help you treat your patients during cardiac recovery:

Monitor Heart Rate

Review weekly, daily, and
5-minute average trends.

View ECGs

View automatic and
patient-initiated recordings.

Conduct a WalkTest®

Measure distance and heart rate— review results from anywhere.

Review Activity Trends

Patient movement is displayed in steps per day.

See Body Position

See patient’s angle—upright, reclined, or lying—over time.

Prescribe a Health Survey

Get patient-reported feedback daily or weekly.

How LifeVest Insight Can Support Your Practice

checklist icon

See opportunities for action

Lifevest amplitude chart
LifeVest informs critical treatment decisions with deeper insight into a patient’s changing condition, helping you achieve a range of treatment goals:
  • Optimization of medical therapy
  • More productive telehealth and follow-up
  • Timely clinical interventions, from ablation to ICD
View case studies
Alerts icon

Customize alerts

Choose how to receive alerts.
Streamline data review by setting custom alerts for clinical events to help optimize your patient’s recovery. Choose the data you want:
  • Automatic and patient-initiated ECG recordings
  • High trending heart rates
  • WCD-guided WalkTest®
Request a demo
Patient icon

Informed patient follow up

Patient and doctor
Assess patient progress during recovery. LifeVest captures trending biometric data that your team can review anytime:
  • Complement patient reported symptoms with objective data
  • Have informed conversations during telehealth & in-office visits
  • Ensure patients remain engaged in follow-up care
View biometric trends dashboard
Network icon

ZOLL Patient Management Network

Doctor on laptop
ZOLL’s flexible data management network provides information upon download from a patient’s LifeVest. Review the LifeVest patient data that you want to see, when you want to see it:
  • Customize alerts to streamline data review
  • See trending biometrics
  • Triage patient review with customizable views
  • Assign data review with staff logins
Request a demo

Enroll

Contact a LifeVest product expert

*LifeVest is designed to monitor heart rhythms continuously, detect certain life-threatening arrythmias, and provide treatment if needed, all of which are localized to the device itself. While LifeVest is designed to transmit patient data when downloaded, no person is reviewing the data in real time.

1

Kutyifa V, Moss A, Klein H, et al. One-Year Follow-Up of the Prospective Registry of Patients Using the Wearable Defibrillator (WEARIT-II Registry). Pacing Clin Electrophysiol. 2018;1–7. https://doi.org/10.1111/pace.13448

2

Kutyifa V, Moss AJ, Klein H, et al. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: Data from the prospective registry of patients using the wearable cardioverter defibrillator (WEARIT-II Registry). Circulation 2015;132(17):1613–1619.

3

Jungbauer CJ, Maier LS, Emoto K, et al. Achieving Guideline-Directed Heart Rate Control Early Posthospitalization, Am J of Cardiology, 2019

>95% consistent, first-shock success across hundreds of thousands of real-world patients. 1-4

1

Kutyifa V, Moss AJ, Klein H, et al. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: Data from the prospective registry of patients using the wearable cardioverter defibrillator (WEARIT-II Registry). Circulation 2015;132(17):1613–1619.

2

Data on file, 90d0241_a01. Report of AArD Performance during 2019.

3

Data on file, 90a0061_a01_revb. Clinical Evaluation Report for LifeVest Wearable Defibrillator, Model 4000, 2021.

4

Chung MK, Szymkiewicz SJ, Shao M, Zishiri E, Niebauer MJ, Lindsay BD, & Tchou PJ (2010). Aggregate national experience with the wearable cardioverter-defibrillator: Event rates, compliance, and survival. Journal of the American College of Cardiology, 56(3), 194–203.

96% effective at terminating VT/VF in a meta-analysis of ~20,000 patients. 1

1

Nguyen E, Weeda E, Kohn C, et al. Wearable cardioverter-defibrillators for the prevention of sudden cardiac death: A meta-analysis. The Journal of Innovations in Cardiac Rhythm Management. 2018;9:3151–3162.

Request a demo of ZOLL Patient Management Network